Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Diazoxide Choline Controlled-Release · 1 trial · 2 indications
Fasting triglycerides (percent change from Baseline to Day 84)
| Arm | Type | Description |
|---|---|---|
| DCCR | EXPERIMENTAL | DCCR Treatment with 290 mg Diazoxide Choline |
| Placebo | PLACEBO_COMPARATOR | Placebo matching DCCR |
| Name | Type | Description |
|---|---|---|
| Diazoxide Choline Controlled-Release Tablet | DRUG | DCCR 290 mg once a day for 126 days |
| Placebo | DRUG | Placebo matching DCCR |
INCLUSION CRITERIA: Fasting triglycerides * Difference between Visit 3 (7 days prior to Baseline Visit) and Visit 4 (3 days prior to Baseline Visit) ≤ 60% (compared to the higher value of Visit 3 or Visit 4) * Run-in Triglycerides\* ≥ 500 mg/dL and \< 1500 mg/dL \*Run-in Triglyceride is defined as...